Search details
1.
Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
Clin Infect Dis
; 58(11): 1549-53, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24633686
2.
Update on HIV/HCV coinfection.
Curr HIV/AIDS Rep
; 10(3): 226-34, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23832718
3.
Directly acting antivirals against hepatitis C virus.
J Antimicrob Chemother
; 66(8): 1673-86, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21652618
4.
COVID-19 in Madrid: Leading Pandemic Control after being the Spanish Epicenter.
AIDS Rev
; 23(2): 115-116, 2021 Jun 07.
Article
in English
| MEDLINE | ID: mdl-34097375
5.
Coronavirus and other airborne agents with pandemic potential.
Curr Opin Environ Sci Health
; 17: 41-48, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32995685
6.
Use of antibiotics in respiratory viral infections.
Intern Emerg Med
; 17(6): 1569-1570, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35298781
7.
Treatment as Prevention: Should Hepatitis C Learn the Lessons from HIV?
AIDS Rev
; 19(4): 212-218, 2017.
Article
in English
| MEDLINE | ID: mdl-29271971
8.
Dual antiretroviral therapy for HIV infection.
Expert Opin Drug Saf
; 16(8): 923-932, 2017 Aug.
Article
in English
| MEDLINE | ID: mdl-28621159
9.
Acute Viral Hepatitis in Men Having Sex with Men.
AIDS Rev
; 22(3): 168-172, 2020.
Article
in English
| MEDLINE | ID: mdl-33118532
10.
Emerging antiretroviral drugs.
Expert Opin Pharmacother
; 15(2): 211-9, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24289800
11.
Towards hepatitis C eradication from the HIV-infected population.
Antiviral Res
; 105: 1-7, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24534673
12.
Pharmacogenetics of antiretroviral therapy.
Expert Opin Drug Metab Toxicol
; 10(8): 1119-30, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24941049
13.
Dolutegravir, abacavir and lamivudine as HIV therapy.
Expert Opin Pharmacother
; 15(7): 1051-7, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24754315
14.
Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy.
AIDS
; 28(10): 1473-8, 2014 Jun 19.
Article
in English
| MEDLINE | ID: mdl-24637541
15.
Once-daily raltegravir moving ahead.
AIDS Rev
; 15(4): 238-9, 2013.
Article
in English
| MEDLINE | ID: mdl-24322385
16.
Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy.
AIDS
; 27(7): 1129-34, 2013 Apr 24.
Article
in English
| MEDLINE | ID: mdl-23276803
17.
Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV-hepatitis C virus coinfected patients.
AIDS
; 27(7): 1187-8, 2013 Apr 24.
Article
in English
| MEDLINE | ID: mdl-23739226
18.
Hepatitis C therapy with HCV NS5B polymerase inhibitors.
Expert Opin Pharmacother
; 14(9): 1161-70, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23621117
19.
Management of hepatitis C in HIV and/or HBV co-infected patients.
Best Pract Res Clin Gastroenterol
; 26(4): 517-30, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-23199509
20.
Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.
Infect Dis Clin North Am
; 26(4): 931-48, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23083825